DPP-IV-IN-2

CAS No. 136259-18-2

DPP-IV-IN-2( H-Lys(4-nitro-Z)-pyrrolidide )

Catalog No. M26242 CAS No. 136259-18-2

DPP-IV-IN-2 is an inhibitor of both DP8/9 and dipeptidyl peptidase IV (IC50s: 0.1 and 0.95 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 88 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DPP-IV-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    DPP-IV-IN-2 is an inhibitor of both DP8/9 and dipeptidyl peptidase IV (IC50s: 0.1 and 0.95 μM).
  • Description
    DPP-IV-IN-2 is an inhibitor of both DP8/9 and dipeptidyl peptidase IV (IC50s: 0.1 and 0.95 μM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    H-Lys(4-nitro-Z)-pyrrolidide
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    DPP
  • Recptor
    NO Synthase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    136259-18-2
  • Formula Weight
    378.429
  • Molecular Formula
    C18H26N4O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 200 mg/mL (528.51 mM)
  • SMILES
    N[C@@H](CCCCNC(=O)OCc1ccc(cc1)[N+]([O-])=O)C(=O)N1CCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kuete V, Ango PY, et al. Cytotoxicity of four Aframomum species (A. arundinaceum, A. alboviolaceum, A. kayserianum and A. polyanthum) towards multi-factorial drug resistant cancer cell lines. BMC Complement Altern Med. 2014 Sep 19;14:340.
molnova catalog
related products
  • P32/98 hemifumarate

    P32/98 hemifumarate is a dipeptidyl peptidase IV (DPP4) inhibitor with hypoglycemic properties that improves insulin sensitivity and β-cell responsiveness in the Zucker diabetic rat model, and may be useful in studies of type 2 diabetes and colitis.

  • Evogliptin

    A potent, long acting, reversible and competitive DPP-4 inhibitor with IC50 of 0.9 nM.

  • AN2718

    AN2718 is a benzoxaborole compound that displays broad antifungal effectiveness in vitro.